Effect | None |
Trial Design | Double blind |
Trial Length | 1-6 months |
Number of Subjects | 138 |
Sex | Both Genders |
Age Range | 30-44, 45-64, 65+ |
Body Types | Average |
Supplementation of colostrum (1,200mg, conferring 500mg immunoglobulins) failed to appreciably influence various immune parameters and DTH responsiveness relative to placebo.